Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM

NCT00378755 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: velcade

Sponsor

Korean Multiple Myeloma Working Party

Collaborators

[object Object]